What are the visuo-motor tendencies of omnidirectional scene free-viewing in virtual reality?


Journal

Journal of vision
ISSN: 1534-7362
Titre abrégé: J Vis
Pays: United States
ID NLM: 101147197

Informations de publication

Date de publication:
02 03 2022
Historique:
entrez: 24 3 2022
pubmed: 25 3 2022
medline: 5 4 2022
Statut: ppublish

Résumé

Central and peripheral vision during visual tasks have been extensively studied on two-dimensional screens, highlighting their perceptual and functional disparities. This study has two objectives: replicating on-screen gaze-contingent experiments removing central or peripheral field of view in virtual reality, and identifying visuo-motor biases specific to the exploration of 360 scenes with a wide field of view. Our results are useful for vision modelling, with applications in gaze position prediction (e.g., content compression and streaming). We ask how previous on-screen findings translate to conditions where observers can use their head to explore stimuli. We implemented a gaze-contingent paradigm to simulate loss of vision in virtual reality, participants could freely view omnidirectional natural scenes. This protocol allows the simulation of vision loss with an extended field of view (\(\gt \)80°) and studying the head's contributions to visual attention. The time-course of visuo-motor variables in our pure free-viewing task reveals long fixations and short saccades during first seconds of exploration, contrary to literature in visual tasks guided by instructions. We show that the effect of vision loss is reflected primarily on eye movements, in a manner consistent with two-dimensional screens literature. We hypothesize that head movements mainly serve to explore the scenes during free-viewing, the presence of masks did not significantly impact head scanning behaviours. We present new fixational and saccadic visuo-motor tendencies in a 360° context that we hope will help in the creation of gaze prediction models dedicated to virtual reality.

Identifiants

pubmed: 35323868
pii: 2778690
doi: 10.1167/jov.22.4.12
pmc: PMC8963670
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12

Références

J Vis. 2016;16(2):3
pubmed: 26824640
Science. 1979 Oct 26;206(4417):468-9
pubmed: 504987
J Vis. 2009 Sep 09;9(10):6.1-16
pubmed: 19810787
IEEE Trans Vis Comput Graph. 2018 Apr;24(4):1633-1642
pubmed: 29553930
Vision Res. 2011 May 11;51(9):997-1012
pubmed: 21335024
Percept Psychophys. 1997 Apr;59(3):323-46
pubmed: 9136264
Vision Res. 2016 Oct;127:186-197
pubmed: 27491705
Sci Rep. 2017 May 23;7(1):2311
pubmed: 28536434
Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2856-60
pubmed: 15277513
Sci Rep. 2017 Apr 24;7(1):1082
pubmed: 28439075
PLoS One. 2015 Mar 23;10(3):e0121035
pubmed: 25799510
Brain Sci. 2020 Nov 12;10(11):
pubmed: 33198116
J Exp Psychol Hum Percept Perform. 2007 Aug;33(4):753-63
pubmed: 17683226
Am J Psychol. 1980 Jun;93(2):207-34
pubmed: 7406068
J Vis. 2009 Jul 09;9(7):4
pubmed: 19761319
J Vis. 2018 Mar 1;18(3):6
pubmed: 29677321
Brain Res Cogn Brain Res. 2004 Apr;19(2):103-13
pubmed: 15019707
J Exp Psychol Appl. 2002 Jun;8(2):99-117
pubmed: 12075694
Vision Res. 2010 Nov 23;50(23):2577-87
pubmed: 20732344
PLoS One. 2013 Jul 22;8(7):e68326
pubmed: 23894300
J Vis. 2016;16(2):6
pubmed: 27002551
Prog Retin Eye Res. 2006 May;25(3):296-324
pubmed: 16516530
J Vis. 2020 Jul 1;20(7):23
pubmed: 32692829
J Neurophysiol. 1992 Jul;68(1):309-18
pubmed: 1517824
J Physiol. 1979 Feb;287:127-47
pubmed: 311828
J Neurosci Methods. 2003 Sep 30;128(1-2):85-93
pubmed: 12948551
R Soc Open Sci. 2018 Aug 29;5(8):180502
pubmed: 30225041
Vision Res. 2011 Jul 1;51(13):1457-83
pubmed: 21237189
J Neurophysiol. 1995 Feb;73(2):766-79
pubmed: 7760133
J Neurophysiol. 1997 May;77(5):2328-48
pubmed: 9163361
J Vis. 2019 May 1;19(5):15
pubmed: 31100131
Psychol Rev. 2010 Apr;117(2):382-405
pubmed: 20438231
J Neurosci Methods. 2016 Dec 1;274:13-26
pubmed: 27693470
Behav Res Methods Instrum Comput. 2002 Nov;34(4):491-9
pubmed: 12564553
Invest Ophthalmol. 1975 Jun;14(6):468-9
pubmed: 1132942
Brain Res. 1972 May 12;40(1):45-8
pubmed: 4624490
Vision Res. 2000;40(16):2083-90
pubmed: 10878269
J Vis. 2019 Dec 2;19(14):22
pubmed: 31868896
J Exp Psychol. 1974 Jul;103(1):62-70
pubmed: 4424680
Psychon Bull Rev. 2014 Oct;21(5):1244-9
pubmed: 24696389
Vision Res. 2011 Sep 1;51(17):1920-31
pubmed: 21784095
J Neurophysiol. 1987 Sep;58(3):427-59
pubmed: 3655876
Neurosci Biobehav Rev. 2016 Oct;69:49-68
pubmed: 27461913
Exp Brain Res. 2008 Oct;190(4):369-87
pubmed: 18704387
Hum Factors. 2003 Summer;45(2):307-28
pubmed: 14529201
Atten Percept Psychophys. 2011 Jan;73(1):266-83
pubmed: 21258925
Cyberpsychol Behav. 2004 Dec;7(6):621-34
pubmed: 15687796
Science. 2002 Mar 29;295(5564):2460-2
pubmed: 11923539
J Vis. 2016 Jan 1;16(2):8
pubmed: 27271524
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3189-3198
pubmed: 29971443
J Vis. 2007 Nov 21;7(14):4.1-17
pubmed: 18217799
Vision Res. 2010 Dec;50(24):2766-74
pubmed: 20932993
Trends Cogn Sci. 2005 Apr;9(4):188-94
pubmed: 15808501
Network. 2007 Sep;18(3):267-97
pubmed: 17926195
J Neurophysiol. 2000 Jul;84(1):376-89
pubmed: 10899212
J Vis. 2012 Feb 09;12(2):
pubmed: 22323822
Optom Vis Sci. 2005 Jan;82(1):27-35
pubmed: 15630401
Philos Trans R Soc Lond B Biol Sci. 2014 Jan 06;369(1636):20130044
pubmed: 24395971
J Vis. 2016;16(2):5
pubmed: 27002550
J Vis. 2013 Oct 16;13(12):11
pubmed: 24133291
Exp Brain Res. 2012 Mar;217(1):125-36
pubmed: 22183755
R Soc Open Sci. 2017 Jan 18;4(1):160569
pubmed: 28280554
Vision Res. 1993 Jan;33(2):211-20
pubmed: 8447094
Vision Res. 2008 Aug;48(17):1777-90
pubmed: 18599105
J Exp Psychol Hum Percept Perform. 2014 Feb;40(1):342-60
pubmed: 23937216
Vision Res. 2010 Apr 7;50(8):779-95
pubmed: 20144645
Atten Percept Psychophys. 2011 Nov;73(8):2384-98
pubmed: 21837543
Exp Brain Res. 1999 May;126(1):41-54
pubmed: 10333006
Perception. 1999;28(11):1311-28
pubmed: 10755142
J Vis. 2011 May 27;11(5):5
pubmed: 21622729
Curr Biol. 2004 Oct 5;14(19):R850-2
pubmed: 15458666
Vis Neurosci. 1990 Aug;5(2):107-22
pubmed: 2278939
Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2765-72
pubmed: 18515599

Auteurs

Erwan Joël David (EJ)

Department of Psychology, Goethe-Universität, Frankfurt, Germany.
david@psych.uni-frankfurt.de.

Pierre Lebranchu (P)

LS2N UMR CNRS 6004, University of Nantes and Nantes University Hospital, Nantes, France.
pierre.lebranchu@chu-nantes.fr.

Matthieu Perreira Da Silva (M)

LS2N UMR CNRS 6004, University of Nantes, Nantes, France.
matthieu.perreiradasilva@univ-nantes.fr http://www.perreira.net/matthieu/about/.

Patrick Le Callet (P)

LS2N UMR CNRS 6004, University of Nantes, Nantes, France.
patrick.lecallet@univ-nantes.fr http://pagesperso.ls2n.fr/~lecallet-p/index.html.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH